Dr Gil Morgan from OncoAlert gives his oncology highlights from social media for the week of March 01 - 06, 2021
Alerts this week cover papers from New England, JAMA Oncology, ESMO Open and Lancet Oncology.
Dr Morgan also highlights the approval of lorlatinib to first line for ALK non-small cell lung cancer and encourages.
You can watch Dr Morgan's previous roundup here.
Follow Dr Morgan on twitter: @OncoAlert
Follow ecancer on twitter: @ecancer